Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. - Wikidata - awgldk - TriplyDB

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.

http://www.wikidata.org/entity/Q45324493

about

Advances in the treatment of newly diagnosed glioblastoma Oligodendroglioma: pathology, molecular mechanisms and markers Case comparison and literature review of glioblastoma: A tale of two tumors Advances in diagnostic and treatment modalities for intracranial tumors.Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.Prognostic and predictive biomarkers: tools in personalized oncology.The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma.Personalized medicine for gliomas The future of high-grade glioma: Where we are and where are we going.Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry.Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma.MGMT testing--the challenges for biomarker-based glioma treatment.Towards developing biomarkers for glioblastoma multiforme: a proteomics view.Pharmacologic therapies for malignant glioma: a guide for clinicians.Epigenetic alterations in cancer and personalized cancer treatment.Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.Chemotherapy in glioma.Anaplastic glioma: current treatment and management.Glioblastoma: pathology, molecular mechanisms and markers.Diagnostic, prognostic and predictive relevance of molecular markers in gliomas.Molecularly based management of gliomas in clinical practice.Emerging circulating biomarkers in glioblastoma: promises and challenges.Recent developments in predictive biomarkers of pediatric glioma The Diagnostic Use of Immunohistochemical Surrogates for Signature Molecular Genetic Alterations in Gliomas.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Advances in the molecular genetics of gliomas - implications for classification and therapy.Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas Milestones of the last 10 years: CNS cancer DNA methylation in adult diffuse gliomas.

P2860

Q26773514-1A963B6F-53B0-42CF-8A47-2F911EFB24AE Q27002448-8ED16FD6-5A9A-402F-95FB-C65E7A333D67 Q27014996-FA05CC32-3EF6-4CD0-8C17-F87D4FC48996 Q30358150-9074D8FA-AFE1-4858-B04E-B90DF63CDA2D Q30402547-9A0CE57C-9DD8-4E88-99DD-D31B72D69C66 Q30836702-B573E215-6C3F-4926-9995-2FC880D1C6F6 Q33651583-E34F840E-F036-4877-8CBE-C46B262FDBF4 Q34061985-2833B1E6-685F-492B-B227-88B42ABE92B5 Q34498352-44A79D83-78FA-408E-BC0D-3E4FF7A66BAE Q34501052-074BBDF9-78E7-4567-BFFB-1FDC8EA17CCB Q35114080-C1B761DF-1F9F-416C-A38D-91A8419E5C68 Q35114090-383A2B0E-C780-40AE-B609-6E11AD13B7A7 Q35572487-E731836D-BF1B-4F13-BE61-43B428B242AB Q35787908-D302C919-E332-46DB-8AA5-61E31F576311 Q36037961-807E4922-A3D6-40B3-AB69-3D86231114A0 Q36069167-ECCD92D9-C6DA-4537-ACF0-B1C67E99737F Q36344709-3DC22340-871D-4A49-8147-C6B63032B1A7 Q36562205-D20CEA7D-DDA1-4B13-91E3-842994BB7F46 Q36705913-33DE03D3-9B86-4A40-9BD2-BB41E79E4E51 Q37694886-A12DE667-7320-4A86-8059-17D4029234AF Q38178105-8904DA80-9C6D-4129-BBE6-2A97C6FBA2E9 Q38218848-9F0F303E-D71D-4DF1-B317-2859E95CC1D6 Q38239173-71EA01F4-D0CA-4AD5-8499-55265C767CD0 Q38268897-138C156E-4333-4DDB-B5A4-DC4AB51F1FF5 Q38319591-214D990D-E036-4D57-91B0-CD09C0551EFA Q38390616-016EBD33-EA7A-42E7-AF99-315D8F643C33 Q38438439-F086ABA1-6921-4D10-AEAB-EFB027FE9165 Q38456018-2A6580A4-233B-4404-8058-A6D5CB90BB4C Q38460865-5F26E4AB-2561-4291-9DD5-E8F0D2250947 Q38461565-EC2010E3-FF62-4413-8187-0EC719B830AA Q38551010-49FA328E-74A3-4BEE-8522-A2E5D9815AC9 Q38591062-84762C43-5932-4942-8415-45FCEA6FC029 Q38660101-FA294D18-9F70-4AE9-962A-209B8573BA1C Q38670567-0694434E-C948-40F4-8619-66BA2CBF6201 Q38743138-E7C9AFF7-0F94-4AC2-878C-D3EBBEF27B93 Q38777058-6DF552A7-0B8D-4561-822F-7D4AAE0F93E5 Q38816272-909C898D-F5A5-4C76-AAF8-C9371162001A Q38843549-AA3699E8-8D60-43C6-8745-44C9B71302AA Q38861548-85484B2B-D437-4404-B0CD-8444118A0B94 Q38861997-64469F60-65C3-4116-9DBC-EF40E50F97AD

P2860

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.

http://www.wikidata.org/entity/Q45324493

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Prognostic or predictive value ...... omas depends on IDH1 mutation.

@en

type

label

Prognostic or predictive value ...... omas depends on IDH1 mutation.

@en

prefLabel

Prognostic or predictive value ...... omas depends on IDH1 mutation.

@en

P1433

Q45324493-B13D1628-A535-4683-8AA6-C16A3F83E787

P1476

Q45324493-B47F50D1-139A-4269-A300-0057F311E7B8

P2093

Q45324493-1B377BB1-8AD3-4923-BF5E-73D27B7CD294

Q45324493-41C9E654-FC5B-49F7-A83E-5AC33E2031D0

Q45324493-5484BE43-C559-44E7-9C0F-8CB4316053DC

Q45324493-5A2AEB27-424D-4588-8B64-B98C93490766

Q45324493-72263784-2706-4323-8583-17A3E3FF6C45

Q45324493-7FE32CAD-B7E4-4AE8-9474-25FA6A6B48FE

Q45324493-91F47F09-1BD2-4B7B-B883-59E3DE7BBD62

Q45324493-AC1B813D-B543-4788-A131-4351BAC88041

Q45324493-ADF23366-3C09-4535-948A-833C84397472

Q45324493-CCFDF785-557D-47A3-9410-93CD8E59A343

P304

Q45324493-A962D3A1-AFF7-4EE8-A0F2-FA0F7E7FB8AA

P31

Q45324493-FE18951C-B00D-4F17-BE32-C142991A649E

P356

Q45324493-914B6538-846C-4F1C-9E8C-4D458B76C31D

P407

Q45324493-AFC67A54-3750-4C86-A968-A21744335CAE

P433

Q45324493-E6EE2A8A-2F50-4A37-B33E-D3874CDAF074

P478

Q45324493-01A15A0A-DF2C-4904-B94C-7857B2BD23E1

P50

Q45324493-3C40E0AE-3706-4A91-B957-D9732D1C9820

Q45324493-6073518B-92D0-4002-8936-19298A65037C

Q45324493-A52D4126-9C53-433C-901D-85448E8CD469

Q45324493-B3ECC0A1-4D3B-49EF-973D-18980D2B006E

Q45324493-D563C2D9-EE9C-4E18-8079-81727B23BFD9

Q45324493-D964BB24-5AA7-45FD-900D-1DAFBFFA3047

P577

Q45324493-C71E985B-6B63-40F5-80E7-583E894AA834

P698

Q45324493-E2DA9891-294E-4CCD-99C3-4F7D3D440975

P356

WNL.0B013E3182A95680

P1433

P1476

Prognostic or predictive value ...... omas depends on IDH1 mutation.

@en

P2093

Alissa Schilling

http://www.w3.org/2001/XMLSchema#string

Benedikt Wiestler

http://www.w3.org/2001/XMLSchema#string

Bettina Hentschel

http://www.w3.org/2001/XMLSchema#string

Christoph Meisner

http://www.w3.org/2001/XMLSchema#string

Dorothee Gramatzki

http://www.w3.org/2001/XMLSchema#string

Gabriele Schackert

http://www.w3.org/2001/XMLSchema#string

Manfred Westphal

http://www.w3.org/2001/XMLSchema#string

Markus Loeffler

http://www.w3.org/2001/XMLSchema#string

Markus Weiler

http://www.w3.org/2001/XMLSchema#string

Matthias Simon

http://www.w3.org/2001/XMLSchema#string

P304

1515-1522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3182A95680

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Guido Reifenberger

Michael Platten

Andreas von Deimling

Ghazaleh Tabatabai

P577

2013-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24068788

http://www.w3.org/2001/XMLSchema#string